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Quantitative Differentiation of Human Serum Alkaline Phosphatase
Isoenzymes with Polyacrylamide Disc Gel Electrophoresis
By P. G. DINGJAN, T. POSTMA and J. A. P. STROES
Department of Clinical Chemistry, Stichting Samenwerking Delftse Ziekenhui^en, D elf t, The Netherlands
(Eingegangen am 31. August 1972/24. Januar 1973)
The separation of alkaline phosphatase (EC 3.1.3.1) isoenzymes by means of polyacrylamidc disc gel electrophoresis is described. The
electrophoretic quantitation of the alkaline phosphatase isoenzymes and the ratio of bone-type fraction/liver-type fraction gives more
clinical information than the heat-inactivation method.
It is demonstrated that the described electrophoretic method together with the determination of y-glutamyl-transpeptidase (EC 2.3.2.1)
and S'-nucleotidase (EC 3.1.3.5) is a reliable and a satisfactory method in the routine hospital laboratory for the differentiation of bone and
hepatobiliary diseases.
Die Trennung der Isoenzyme der alkalischen Phosphatase (EC 3.1.3.1) mit der Polyacrylamidgel-Disc-Elektrophorese wird beschrieben.
Die elektrophoretische Bestimmung der Isoenzyme der alkalischen Phosphatase und des Quotienten Knochentyp-Fraktion/Lebertyp-
Fraktion gibt mehr Information für die Klinik als die Hitze-Inaktivierungs-Methode.
Es wird gezeigt, daß die beschriebene elektrophoretische Methode zusammen mit der Bestimmung der y-Glutamyltranspeptidase
(EC 2.3.2.1) und S'-Nucleotidase (EC 3.1.3.5) eine zuverlässige und befriedigende Methode zur Differenzierung von Knochen- und
Leber-Galle-Erkrankungen im klinischen Routinelaboratorium ist.
The determination of alkaline phosphatase (EC 3.1.3.1)
is one of the most frequently requested analyses in the
hospital laboratory.
An elevated alkaline phosphatase is usually the result of
hepatobiliary or bone diseases.
The S'-nucleotidase (EC 3.1.3.5) and y-glutamyltrans-
peptidase (EC 2.3.2.1) determinations can, of course,
be used to differentiate between bone and liver diseases,
but methods for differentiating alkaline phosphatase
isoenzymes as a basis for diagnosis frequently appear
in the literature (1—7).
In healthy normal non-pregnant subjects, only the small
intestine-type alkaline phosphatase, bone-type alkaline
phosphatase and liver-type alkaline phosphatase appear
in serum.
In healthy pregnant subjects in the third trimester of
gravidity, an extra placenta-type alkaline phosphatase
appears together with an increase of total alkaline
phosphatase activity.
Patients with intra- or extrahepatic obstruction very
often have an extra cholestatic type (bile-type) alkaline
phosphatase (3, 4).
Occasionally, other alkaline phosphatase isoenzyme
types are found in human serum (3, 5).
Electrophoresis on paper, agar, starch or cellulose-
acetate and column chromatography (1, 2) are either
difficult to interprete or time-consuming.
Heat-inactivation combined with stereospecific in-
hibition of serum with L-phenylalanine (6) is a con-
venient, rapid technique, but in our opinion, it gives
less information about the alkaline phosphatase iso-
enzymes.
Of the electrophoretic techniques, the polyacrylamide
disc gel method is the most suitable (7, 8).
In the literature, the results obtained by electrophoresis
are rarely submitted to a quantitative evaluation. This
could be due to the bad separation and staining techni-
ques used.
Materials and Methods
Selection of sera
Normal sera were gathered from 95 donors. All sera had normal
alkaline phosphatase activity. Only three presented elevated
y-glutamyltranspeptidase and 5'-nucleotidase and were not
examined further. The remaining 92 subjects (39 female and 53
male) ranged in age from 21 to 65 years with a median age of
34 years.
Abnormal sera were selected from patients, which had elevated
alkaline phosphatase activity (over 65IU/1) and in which the
clinical diagnosis was confirmed by histological, roentgenological
and radiological examination, or laporatomy or autopsy.
They were grouped according to their clinical disorder as follows:
1. 25 patients with hepatobiliary diseases: liver metastases (9);
cholecystitis chronica (4); cholelithiasis (4); obstructive jaundice
(3); extrahepatic obstruction (2); cholecystitis acuta (1); cirrhosis
of liver (1); non-specific liver degeneration (1). (Minimum age
47 and maximum age 87 years with a median of 62 years.)
2. 15 patients with bone diseases: malignant bone diseases with
osteoblastic activity (9); healing phase of bone fractures (2);
FACET'S disease (2); KAHLER'S disease (1); osteomalacia (1).
(Minimum age 51 and maximum age 81 with a median of 61
years.)
3. 1 patient (47 years) liver and bone metastases.
4. 4 patients (51, 61, 21 and 74 years old) with diseases other than
'bone or liver diseases.
Polyacrylamide disc gel electropboresis
25 serum samples were elcctrophoresed in a discontinuous
buffer and gel system in glass tubes (5 mm X 75 mm; cleaned
with Tween-20) with a separating gel of 45 mm for one hour
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at 3 mA/gel at room temperature according to the instructions of
the manufacturer (acrylamide 7%; bisacrylamide 0.18%) (9).
It is possible to prepare, run and stain 12 samples simultaneously
in about 41I2 h.
The substrate solution for staining the alkaline phosphatase frac-
tions after elcctrophoresis consisted of ^-toluidinium-5-bromo-4-
chloro-3-indolyl phosphate, dimethylformamide, and a buffer.
It gave weak to very intense blue bands, with no background
colour. The bands were very stable in 7% acetic acid at room
temperature.
It is important to take an aliquot part of the serum, i. e. reduce
the sample load, when the alkaline phosphatase activity is above
100IU/1. This avoids uneven staining and helps in the inter-
pretation of the electrophoretic pattern. The incubation time must
be standardized. This method does not influence the relative ratio
between the isoenzyme fractions.
The bone-type/liver-type alkaline phosphatase ratio was calculated
densitometrically.
Quantitation of the alkaline phosphatase isoenzyme fractions was
carried out by means of the Kipp Model DD2 Microdensitometer
at 580—650 nm and the Kipp Model BC1 Integrator (Kipp &
Zonen, Delft, Holland).
The gels were scanned in glass tubes filled with 7% acetic
acid solution and were placed horizontally on a flat perspex
holder. The linear velocity past the light source was 20 mm/min.
The integrator was started and stopped manually. For overlapping
peaks the approximation was used that the area between two
imaginary perpendicular lines between the minima of two peaks
was representative of the relative activity of the isoenzyme frac-
tions.
Although the quantitative differentiation of incompletely sepa-
rated curves is theoretically difficult, it was evident that the above
mentioned approximation was satisfactory on a practical basis
(see Table 1).
For identification of the bands, tissue extracts were made with
Λ-butanol : 500 mg tissue, (frozen at — 60°C before use) was
homogenised, according to a modified procedure of MORTON
(8, 10), for about 10 min in 2 ml of 20% «-butanol solution at
0°C. (Tri-R homogeniser S 220, with a glass reinforced teflon
pestle with a clearance of 0.11 — 0.15 mm; Tri-R Instruments,
Inc., 48 Merrick Road, 11570 Rockville Centre N. Y., USA.)
After centrifugation and storage overnight at 4°C, the supernatant
was electrophoresed.
This treatment when applied to sera, caused no detectable change
in the isoenzyme pattern or in the relative isoenzyme electro-
phoretic mobilities.
Alkaline phosphatase activity
Alkaline phosphatase activity was measured by incubating 0.1 ml
serum for exactly 15 min at 37°C in 1 ml of substrate-buffer
(0.61 mol/1 2-amino-2-methyl-propan-l-ol, 0.018 mol/1 4-nitro-
phenyl disodium orthophosphate and 0.001 mol/1 MgQ2 · 6 H2O
at pH 10.5).
The reaction was stopped with 10 ml 1 mol/1 NaOH solution and
absorbance was measured at 405 nm.
The results were expressed in IU/1.
The normal values for adults were 37 ±19.8 IU/1 (N = 92;
x±2SD).
Heat-inactivation-T*-pbenylalanine inhibition
Sera were heat-inactivated as follows:
0.5 ml serum was pipetted into 53 mm X 9.5 mm test tubes at
room temperature and stoppered.
The tubes were placed in a suitable incubating rack, then immersed
'in a waterbath at 56 ± 0.5°C for exactly 15 min.
The rack with tubes was immediately placed in an ice-water-bath
for several minutes, then allowed to remain at room temperature.
The alkaline phosphatase activity was measured within 1 h. The
alkaline phosphatase activity for the serum before and after heat-
inactivation was measured in the substrate-buffer solution con-
taining O.Q05 mol/1 L-phenylalanine (6).
The Q-value is defined as:
Alkaline phosphatase activity after heat-inactivation with
L-phenylalanine
^ ~~ Alkaline phosphatase activity before heat-inactivation with
L-phenylalanine
This Q-value gives the ratio between the heat-labile bone-type
phosphatase and the relatively heat-stable liver-type phosphatase.
L-phenylalanine inhibits the small intestine-type phosphatase.
j
5'-Nucleotidase
5'-nucleotidase was measured with the manual method of PERSIJN
and VAN DER SLIK et al. (11).
Normal values: 3.5—11.0 IU/1.
y-Glutamyltranspeptidase
The y-glutamyltranspeptidase was measured by the manual
method of SZASZ (12).
Normal values: male 6—28 IU/1
female 6—18 IU/1.
Results
Precision
The precision of the electrophoretic method was tested
with two sera which- were different in the ratio of
bone-type to liver-type alkaline phosphatase isoenzymes
(Table 1).
Heat-inactivation (Q-value)
The precision of the heat-inactivation method wa's
investigated with a normal serum.
For results see Table 2.
Normal Values
Poly aery lamide disc gel electrophoresis
The normal values of the alkaline phosphatase iso-
enzyme fractions (in %) were calculated from the
results of 92 sera. Discrimination was made between
sera without and with an intestine-type alkaline phos-
phatase fraction in the electropherogiram, because when
an intestinal fraction is present the percentages of the
bone and liver-type fraction will be lower.
For results see Table 3.
Tab. 1
Precision of the polyacrylamide disc gel electrophoresis
Serum la: n =40, total alkaline phosphatase activity 50'IU/l
Serum Ib: n = 40, total alkaline phosphatase activity 195 IU/1
Bone-type fraction [%]
Liver-type fraction [%]
bone-type fraction
liver-type fraction *allu
Serum la
x±SD
43 ±3.3
57 ±3.3
0.8 ±0.10
Serum Ib
x±SD
68 ±2.4
32 ±2.4
2.1 ±0.24
Tab. 2
Precision of the heat-inactivation (Q-value)
Normal serum: n =40, total alkaline phosphatase activity 30 IU/1
bone fraction 51 %, liver fraction 49%
Q-value
x±SD
Normal serum 0.16 ±0.008
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Tab. 3
Normal values for alkaline phosphatase from disc gel electrophoresis
a) sera without intestine-type fraction; n = 59
b) sera with intestine-type fraction; n — 33
Intestine-type fraction [%]
Bone-type fraction [%]
Liver-type fraction [%]
Bone-type fraction
Liver-type fraction
a
50 ±8.3
50 ±8.3
1.1 ±0.35
b
x±SD
13 ±6.2
42 ±9.6
45 ±9.3
1.0 ±0.42
The mean total alkaline phosphatase activity was
16-55IU/1 (x±2SD) for series 3a and 21-59IU/1
(χ ± 2 SD) for series 3b.
As can be seen from Table 3 the bone/liver type
ratios of the two groups do not differ significantly.
Examples are given in Figure la and lb, of the
electrophoretic results from normal sera with and
without intestine-type phosphatase. A bile-type al-
kaline phosphatase fraction could be detected in none
of the 92 normal sera.
The small response at 1 in Figure 1 is due to the change
in optical density caused by the interface of the se-
parating gel/stacking gel.
Fraction 2 is a very small and weak band often seen in
normal and abnormal sera.
Fraction 3 is a weak intestine-type alkaline phosphatase
isoenzyme that appeared in 36.8% of these sera.
Fraction 4 is the bone-type alkaline phosphatase iso-
enzyme. Fraction 5 is the liver-type alkaline phospha-
tase isoenzyme.
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Tab. 4
Examples of laboratory results from patients with different diseases
Serum Diagnosis
No.
Alkaline
phospha-
tase
5'-Nucleo-
tidase
y-Gluta-
rriyltrans-
peptidase
Q-value Bone/liver
ratio 1
Fraction :
3 4 5
Type:
bile intestine bone
[IU/1] [IU/1] [IU/1]
Bone diseases
6. skeletal metastases 217 9.4 10 0.08 2.8
7. skeletal metastases 217 14.4 38 0.07 1.9
8. KAHLER'S disease 73 6.9 10 0.04 100.0
9. FACET'S disease of bone 85 3.8 22 0.11 1.8
10. skeletal fractures 250 9.7 36 0.04 3.2
Bone and Liver diseases
11. metastases in liver and bone "706 27.5 158 0.04 3.0
73
66
100
64
76
75
liver
Hepatob i l i a ry diseases
1. liver metastases
2. occlusion of bile duct
3. cirrhosis of liver
4. adenomacarcinoma of liver
5. cholelithiasis
427
305
180
740
92
45.2
50.0
49.5
182.0
75.3
71
181
186
320
136
0.28
0.32
0.31
0.30
0.24
0.5
0.0
0.6
0.1
0.6
4- —
16 —
— —24 —
4
t
34
—38
5
36
66
84
62
71
60
27
34
36
24
25
Miscellaneous diseases
12. bronchial carcinoma
13. metastases in lung
14. HODGKIN'S disease
(stage II) '· ·
15 aortic stenosis
103
72
87
132
11.4
9.4
5.7
19.9
45
41
28
213
0.29
0.21
0.23
0.25
0.1
0.0
0.2
0.2
18 —
I
'-!-
+ 15
8
—
15
12
74
100
85
73
Heat-inactivation
For 38 normal sera the mean Q-value was 0.09 with a
standard deviation of 0.027. See also Figure 2.
Applications of the described methods
Hepatobiliary diseases
Examination of sera from 25 patients with different
hepatobiliary diseases gave the following results:
Alkaline phosphatase 80—900 IU/1, y-glutamyltrans-
peptidase 28-363 IU/1, 5'-nucleotidase 11.5-^ 182.0 IU/1,
a mean Q-value of 0.26 with a standard deviation of
0.066 and a bone/liver ratio 0.0—0.7. See Figures 2 and 3.
Examples (sera 1—5) are shown in Table 4.
Figure 4a shows the electrophoretic pattern of a serum
with a high liver-type fraction and positive bile-type
fraction.
Bone diseases
Examination of sera from 15 patients with different
bone diseases yielded the following results: alkaline
Start
Start
Fig. 4 a
Electropherogram of a serum from a 39 year-old man with a T-drain,
fraction 5 = 54%
Fig. 45
from a 61 year-old woman with gene-
alkaline phosphatase 90 IU/1. 5'-nuciec-
tamyltranspeptidase 24 IU/1, bone/liver ratio2.1, fraction 4 = 68%, fraction 5 = 32%
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Tab. 5
Progress of the illness of a woman, 67 years old, with bone metastases
Analysis date
1.2/72
24.2/72
8.3/72
Alkaline
phosphatase
[IU/1]
103
118
102
5'-Nucleo-
tidase
[IU/1]
7.8
14.5
5.1
y-Glutamyl-
Transpeptidase
[IU/1]
41
30
14
Q-value
0.15
0.13
0.13
Bone/liver
ratio
0.9
I.I
2.4
Bone-type
[%]
48
52
71
Liver-type
[%]
52
48
29
phosphatase 80—267 IU/1, y-glutamyltranspeptidase
8—40 IU/1, 5'-nucleotidase 3.8—17.3 IU/1, a mean
Q-value of 0.07 with a standard deviation of 0.018,
and bone/liver ratios from 1.8 to 100.
Examples (sera 6—10) are shown in Table 4.
Figure 4b shows the electrophoretic pattern of a serum
with a high bone-type fraction.
Liver and bone diseases
It is also possible to encounter patients with both liver
and bone diseases. In these cases, the interpretation is
difficult on the basis of the Q-value or bone/liver
ratio alone; other indices of liver functions are needed.
An example (serum 11) is given in Table 4.
Miscellaneous diseases
Cases also exist where the electrophoretic pattern
reveals a high liver fraction, with no clinical evidence
for liver disease.
Examples (sera 12—15) are shown in Table 4.
Following the progress of disease
Table 5 shows an example of a change in alkaline
phosphatase isoenzyme pattern which took place over
6 weeks. On 1. 2. '72 it was difficult to decide ^hether
the bone-type fraction was elevated or not (bone-type
fraction 48%, bone/liver ratio 0.9).
On 8, 3. '72 the bone-type fraction was clearly
elevated (bone-type fraction 71%, bone/liver ratio 2.4).
Discussion and Conclusion
A clinician is often interested in determining the origin
of elevated alkaline phosphatases in serum (13). In our
laboratory, we could never obtain satisfactory results with
the frequently used method of HAIJE and DE JONG (14)
in an agar medium.
After introducing the method of polyacrylamide disc
gel electrophoresis in our laboratory for screening high
alkaline phosphatase sera, together with 5'-nucleotidase
(15, 16) and y-glutamyltranspeptidase (17) and also
with the Q-value, we obtained very good results,
indeed. This electrophoresis method is a good diagnostic
aid for screening and following (Table 5) patients with
bone and hepatobiliary diseases.
The · quantitation of the disc electrophoresis and the
expression of the results in terms of a bone/liver ratio
are especially valuable.
In most cases, there are no difficulties at all in differen-
tiating between bone and liver diseases when using
this ratio (Fig. 3).
There are, of course, cases involving both bone and
liver. In these cases disc electrophoresis gives valuable
information, since the bone fraction is raised, together
with a rise in y-glutamyltranspeptidase and 5'-nucleo-
tidase.
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